94 related articles for article (PubMed ID: 8814356)
1. Preliminary examination of the influence of incubation time or cytosolic protein concentration on dihydropyrimidine dehydrogenase activity.
Tateishi T; Nakura H; Watanabe M; Tanaka M; Kumai T; Kobayashi S
Clin Chim Acta; 1996 Aug; 252(1):1-9. PubMed ID: 8814356
[TBL] [Abstract][Full Text] [Related]
2. (R)-5-fluoro-5,6-dihydrouracil: kinetics of oxidation by dihydropyrimidine dehydrogenase and hydrolysis by dihydropyrimidine aminohydrolase.
Porter DJ; Harrington JA; Almond MR; Lowen GT; Spector T
Biochem Pharmacol; 1994 Aug; 48(4):775-9. PubMed ID: 8080451
[TBL] [Abstract][Full Text] [Related]
3. The activity of dihydropyrimidine dehydrogenase from rat liver was not affected by any of five 5-hydroxytryptamine antagonists.
Tateishi T; Nakura H; Watanabe M; Tanaka M; Kumai T; Kobayashi S
Cancer Lett; 1996 Nov; 108(1):1-5. PubMed ID: 8950202
[TBL] [Abstract][Full Text] [Related]
4. Sex- or age-related differences were not detected in the activity of dihydropyrimidine dehydrogenase from rat liver.
Tateishi T; Watanabe M; Nakura H; Tanaka M; Kumai T; Kobayashi S
Pharmacol Res; 1997 Feb; 35(2):103-6. PubMed ID: 9175577
[TBL] [Abstract][Full Text] [Related]
5. Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase.
Tuchman M; Ramnaraine ML; O'Dea RF
Cancer Res; 1985 Nov; 45(11 Pt 1):5553-6. PubMed ID: 4053028
[TBL] [Abstract][Full Text] [Related]
6. Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy.
Lu Z; Zhang R; Diasio RB
Clin Pharmacol Ther; 1995 Nov; 58(5):512-22. PubMed ID: 7586945
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyrimidine dehydrogenase. Kinetic mechanism for reduction of uracil by NADPH.
Porter DJ; Spector T
J Biol Chem; 1993 Sep; 268(26):19321-7. PubMed ID: 8366081
[TBL] [Abstract][Full Text] [Related]
8. In vitro degradation of pyrimidine bases: studies of rat liver dihydropyrimidine dehydrogenase.
Tuchman M; Ramnaraine ML; O'Dea RF
Adv Exp Med Biol; 1986; 195 Pt B():245-8. PubMed ID: 3766229
[No Abstract] [Full Text] [Related]
9. Dehalogenating and NADPH-modifying activities of dihydropyrimidine dehydrogenase.
Porter DJ
J Biol Chem; 1994 Sep; 269(39):24177-82. PubMed ID: 7929074
[TBL] [Abstract][Full Text] [Related]
10. Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy.
Harris BE; Song RL; He YJ; Soong SJ; Diasio RB
Biochem Pharmacol; 1988 Dec; 37(24):4759-62. PubMed ID: 3202908
[TBL] [Abstract][Full Text] [Related]
11. Dihydropyrimidine dehydrogenase activity and fluorouracil pharmacokinetics with liver damage induced by bile duct ligation in rats.
Tateishi T; Watanabe M; Nakura H; Tanaka M; Kumai T; Sakata SF; Tamaki N; Ogura K; Nishiyama T; Watabe T; Kobayashi S
Drug Metab Dispos; 1999 Jun; 27(6):651-4. PubMed ID: 10348793
[TBL] [Abstract][Full Text] [Related]
12. Liver dihydropyrimidine dehydrogenase activity in human, cynomolgus monkey, rhesus monkey, dog, rat and mouse.
Sludden J; Hardy SC; VandenBranden MR; Wrighton SA; McLeod HL
Pharmacology; 1998 May; 56(5):276-80. PubMed ID: 9597696
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyrimidine dehydrogenase in livers from mouse and rat, and in human liver, colon tumors, and mucosa in relation to anabolism of 5-fluorouracil.
Peters GJ; van Groeningen CJ; Pinedo HM
Adv Exp Med Biol; 1998; 431():633-6. PubMed ID: 9598142
[No Abstract] [Full Text] [Related]
14. Altered dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil containing chemotherapy.
van Kuilenburg AB; Klumpen HJ; Westermann AM; Zoetekouw L; Bakker PJ; Guchelaar HJ; Richel DJ
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):726-32. PubMed ID: 18600532
[TBL] [Abstract][Full Text] [Related]
15. Dihydropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humans.
Guimbaud R; Guichard S; Dusseau C; Bertrand V; Aparicio T; Lochon I; Chatelut E; Couturier D; Bugat R; Chaussade S; Canal P
Cancer Chemother Pharmacol; 2000; 45(6):477-82. PubMed ID: 10854135
[TBL] [Abstract][Full Text] [Related]
16. Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency.
van Kuilenburg AB; Muller EW; Haasjes J; Meinsma R; Zoetekouw L; Waterham HR; Baas F; Richel DJ; van Gennip AH
Clin Cancer Res; 2001 May; 7(5):1149-53. PubMed ID: 11350878
[TBL] [Abstract][Full Text] [Related]
17. Influence of liver dysfunction on dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells.
Nakada T; Yamauchi M; Toda G
Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():230-5. PubMed ID: 11890111
[No Abstract] [Full Text] [Related]
18. DPD functional tests in plasma, fresh saliva and dried saliva samples as predictors of 5-fluorouracil exposure and occurrence of drug-related severe toxicity.
Neto OV; Raymundo S; Franzoi MA; do Carmo Artmann A; Tegner M; Müller VV; Hahn RZ; Alves GV; Schwartsmann G; Linden R; Antunes MV
Clin Biochem; 2018 Jun; 56():18-25. PubMed ID: 29625079
[TBL] [Abstract][Full Text] [Related]
19. [Determination of dihydropyrimidine dehydrogenase in the prediction of toxic side effects of 5-fluorouracil].
Katona C; Rosta A; Tóth K; Fónyad G; Jeney A; Pandi E; Kralovánszky J
Orv Hetil; 1997 Jul; 138(29):1843-7. PubMed ID: 9280881
[TBL] [Abstract][Full Text] [Related]
20. Stereochemistry of NADPH oxidation by dihydropyrimidine dehydrogenase from pig liver.
Podschun B
Biochem Biophys Res Commun; 1992 Jan; 182(2):609-16. PubMed ID: 1734873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
